BETA-BLOCKER THERAPY VERSUS STANDARD CARE IN PATIENTS WITH SEPTIC SHOCK: A PILOT RANDOMIZED CONTROLLED TRIAL UTILIZING PREDICTIVE ENRICHMENT WITH POINT-OF-CARE ULTRASOUND

Registry ID

EPIC-BETA-01

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

LONDON HEALTH SCIENCES CENTRE

Start date

2026-02-02

Last update

2025-12-15

Conditions

• SEPTIC SHOCK
• SEPSIS

Related clinical trials

• INTRAVENOUS DNASE I FOR THE TREATMENT OF SEPSIS: A PHASE I SAFETY AND FEASIBILITY STUDY IN ICU PATIENTS
• UMBILICAL MESENCHYMAL STROMAL CELLS AS CELLULAR IMMUNOTHERAPY FOR SEPTIC SHOCK (UC-CISS II): A MULTI-CENTER, DOUBLE-BLIND, PHASE II RANDOMIZED CONTROLLED TRIAL
• PRAGMATIC PEDIATRIC TRIAL OF BALANCED VERSUS NORMAL SALINE FLUIDS IN SEPSIS (PROMPT BOLUS)
• LESSENING ORGAN DYSFUNCTION WITH VITAMIN C ¿ COVID (LOVIT-COVID)
• LESSENING ORGAN DYSFUNCTION WITH VITAMIN C (LOVIT).
• "RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A TRIAL OF EFFICACY AND SAFETY OF EVOLOCUMAB FOR PCSK9 LOWERING IN EARLY ACUTE SEPSIS. THE (PLEASE) STUDY."

View on source registry